U-PLOID BIOTECHNOLOGIES LTD
Company number 15432020 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£1,806,893
Balance sheet as at 2026-01-31
What it does
72110
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2024-01-22
- Employees
- 6 (2026 accounts · was 3 in 2025)
- Registered office
- Building 696, Innovation Building, Bioescalator Old Road Campus, Roosevelt Drive, Headington, Oxford, England, OX3 7FZ
- Postcode
- OX3 7FZ
- Capital
- 3 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2026-01-31
- Next due by
- 2027-10-31
- Financial year end
- 31 January
Confirmation statement
- Last statement dated
- 2026-08-01
- Next due by
- 2027-08-15
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 4 current
Jeremy James Anthony, Doctor BUZZARD
Director
Jordan, Dr ABDI
Director
Chloe Amelia, Dr CHARALAMBOUS
Director
Alexandre, Dr WEBSTER
Director
Contact details
- Website
- u-ploid.co.uk
U-Ploid is developing a new class of reproductive therapeutics, starting with a treatment to improve egg quality for women in their mid-30s and above.
Among its peers
Top 25%
by shareholders' funds, of 179 similar companies in OX
Trading since 2024.
Competitors Oxford
This company ranks 40 among research and experimental development on biotechnology in Oxford.